Price
274.55
+0.71%52W Range
Market Cap
₹11,858.66 Cr
Traded: ₹12.33 Cr (0.10%) 0.0x
Free Float: ₹869.24 Cr (1.42% of FF traded)
Volume · 60D trend
4.53 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +17.0% | +10.0% | -- | +21.0% | Stable |
| ROE | -- | +24.0% | +19.0% | -- | -- | Decelerating |
| Return | -- | -- | -- | -- | -- | -- |
| Profit | -- | +11.0% | +5.0% | -- | +25.0% | Stable |
Quarterly Results
Jun 2025
Mar 2025
Dec 2024
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales | 476 | 460 | 410 | 410 | 399 | 354 | 348 |
| Expenses | 350 | 333 | 311 | 297 | 294 | 265 | 265 |
| Operating Profit | 126 | 127 | 99 | 113 | 105 | 88 | 83 |
| OPM % | 26.0% | 28.0% | 24.0% | 27.0% | 26.0% | 25.0% | 24.0% |
| Other Income | 8 | 8 | 9 | 8 | 7 | 9 | 15 |
| Interest | 10 | 14 | 15 | 15 | 15 | 16 | 16 |
| Depreciation | 19 | 18 | 15 | 15 | 15 | 16 | 15 |
| Profit Before Tax | 105 | 103 | 78 | 91 | 82 | 66 | 67 |
| Tax % | 16.0% | 26.0% | 32.0% | 14.0% | 20.0% | 20.0% | 32.0% |
| Net Profit | 89 | 77 | 53 | 79 | 66 | 52 | 46 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 1.9 | 1.6 | 1.2 | 1.9 | 1.5 | 1.2 | 3.0 |
| Sales Growth (YoY) | 19.3% | 29.9% | 17.8% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 3.5% | 12.2% | 0.0% | 2.8% | 12.7% | 1.7% | -- |
| OP Growth (YoY) | 20.0% | 44.3% | 19.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | -0.8% | 28.3% | -12.4% | 7.6% | 19.3% | 6.0% | -- |
| Profit Growth (YoY) | -- | 58.0% | 11.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | 26.5% | 40.2% | -60.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 16.5% | 40.2% | -38.7% | 26.5% | 29.1% | -60.6% | -- |
| OP Margin | 26.5% | 27.6% | 24.1% | 27.6% | 26.3% | 24.9% | 23.9% |
| Net Margin | 18.7% | 16.7% | 12.9% | 19.3% | 16.5% | 14.7% | 13.2% |
| Material Cost % | -- | 17.3% | 18.4% | 17.2% | -- | 17.7% | 20.8% |
| Employee Cost % | -- | 18.7% | 20.3% | 18.9% | -- | 20.7% | 20.4% |
| P/S | 6.75 | 7.74 | -- | -- | -- | -- | -- |
| P/E | 41.41 | 49.69 | -- | -- | -- | -- | -- |
| P/B | 5.86 | 6.25 | 9.34 | -- | -- | -- | -- |
Exchange Filings
50Meeting with Analyst/Investors
Transcript of Earnings Conference Call held on August 04, 2026
Notice of Postal Notice
Standalone and Consolidated Results for the Quarter ended 30 June 2026
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026
Meeting with Analyst/Investors
Intimation regarding capacity addition
Intimation regarding closure of trading window
Meeting with Analysts/Investors
Meeting with Analyst/Investors
Announcement regarding divestment
Acquisition of The Medicity Hospital, Rudrapur, Uttarakhand.
Acquisition of The Medicity Hospital, Rudrapur, Uttarakhand
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Incorporation of step down subsidiary
Schedule of Analysts/Investors Meeting
Transcript of Earnings Conference Call held on May 13, 2026
Outcome of Board Meeting held on May 15, 2026
The Board of Directors in its meeting held on May 15, 2026, approved the appointment of Auditors
Key Performance Indicators
Monitoring Agency Report for the Quarter ended March 31, 2026
Newspaper Advertisement regarding Financial Results
Audio Recording of Earnings Conference Call
Outcome of Board meeting for the quarter and financial year ended March 31, 2026
Financial Results for the quarter and year ended March 31 2026
Change in Senior Management Personnel of the Company
Earnings Presentation for Audited Financial Results for the quarter and year ended March 31, 2026
Earnings Release for the financial results for the quarter and year ended March 31, 2026
Schedule of Analyst/Investor Meeting
Park Medi World Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve the standalone and consolidated ....
Incorporation of Wholly owned Subsidiary
Launch of Hospital in Panchkula
Certificate under Regulation 74(5) of SEBI (Depository Participant) Regulations, 2018 for the quarter ended March 31, 2026
Update on Launch of Hospital- Panchkula
Closure of Trading Window
Completion of Acquisition
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund
Launch of Multispecialty Hospital in Panchkula and expansion of Mohali Hospital
Outcome of Board Meeting held on March 10, 2026 for launch of Hospital in Panchkula and Expansion of Bed Capacity at Grecian Super Speciality Hospital, Mohali.
Intimation regarding Analyst/Investor Meeting scheduled on March 14, 2026
Intimation regarding Investors Meeting scheduled on March 09, 2026.
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, -Meeting with Analysts/Investors
Update on the Acquisition
Monitoring Agency Report for the Quarter ended December 31, 2025
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for analyst/investor meeting
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for meeting with analyst/Investors
Representatives of the management of Park Medi World will participate in Corporate Conference 2026: Decoding Growth Strategies organized by Dolat Capital on Feb 18, 2026
Transcript of Earnings Conference call held on January 29, 2026
Update on Acquisition
Link of audio recording of earning conference call
Concalls
1Feb 2026
28 Feb 2026Held by ETFs
3 ETFs hold parkhosps · sorted by weight
Held by Mutual Funds
13 schemes hold parkhosps · sorted by weight